DE-117 Spectrum 5 Study
NCT03697811
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Open-angle Glaucoma and Ocular Hypertension
Interventions
DRUG:
DE-117 Ophthalmic Solution
Sponsor
Santen Inc.